Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations
Open accessAbstract
Importance: The association between major depressive disorder (MDD) and obesity may stem from shared immunometabolic mechanisms particularly evident in MDD with atypical features, characterized by increased appetite and/or weight (A/W) during an active episode. Objective: To determine whether subgroups of patients with MDD stratified according to the A/W criterion had a different degree of genetic overlap with obesity-related traits (body mass index [BMI] and levels of C-reactive protein [CRP] and leptin). Design, Setting, and Patients: This multicenter study assembled genome-wide genotypic and phenotypic measures from 14 data sets of the Psychiatric Genomics Consortium. Data sets were drawn from case-control, cohort, and population-based studies, including 26 628 participants with established psychiatric diagnoses and genome-wide genotype data. Data on BMI were available for 15 237 participants. Data were retrieved and analyzed from September 28, 2015, through May 20, 2017. Main Outcomes and Measures: Lifetime DSM-IV MDD was diagnosed using structured diagnostic instruments. Patients with MDD were stratified into subgroups according to change in the DSM-IV A/W symptoms as decreased or increased. Results: Data included 11 837 participants with MDD and 14 791 control individuals, for a total of 26 628 participants (59.1% female and 40.9% male). Among participants with MDD, 5347 (45.2%) were classified in the decreased A/W and 1871 (15.8%) in the increased A/W subgroups. Common genetic variants explained approximately 10% of the heritability in the 2 subgroups. The increased A/W subgroup showed a strong and positive genetic correlation (SE) with BMI (0.53 [0.15]; P = 6.3 × 10-4), whereas the decreased A/W subgroup showed an inverse correlation (-0.28 [0.14]; P = .06). Furthermore, the decreased A/W subgroup had a higher polygenic risk for increased BMI (odds ratio [OR], 1.18; 95% CI, 1.12-1.25; P = 1.6 × 10-10) and levels of CRP (OR, 1.08; 95% CI, 1.02-1.13; P = 7.3 × 10-3) and leptin (OR, 1.09; 95% CI, 1.06-1.12; P = 1.7 × 10-3). Conclusions and Relevance: The phenotypic associations between atypical depressive symptoms and obesity-related traits may arise from shared pathophysiologic mechanisms in patients with MDD. Development of treatments effectively targeting immunometabolic dysregulations may benefit patients with depression and obesity, both syndromes with important disability.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Obese individuals, particularly those presenting attributes of metabolic syndrome, tend to develop the atypical subtype of depression.
“Obese individuals, particularly those presenting attributes of metabolic syndrome (abdominal obesity, hyperglycemia, hypertension, elevated triglycerides), tend to develop the atypical subtype [9] (Box 1).”
From The menace of obesity to depression and anxiety prevalence (2022) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090 · see citing works
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,501 · see citing works
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577 · see citing works
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534 · see citing works
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322 · see citing works
Self-citationThe role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · see citing works
Toward the future of psychiatric diagnosis: the seven pillars of RDoC
Cuthbert, B. N., & Insel, T. R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-126 · Cited by 3,053 · see citing works
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · see citing works
The cellular and signaling networks linking the immune system and metabolism in disease
Osborn, O., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2627 · Cited by 1,551 · see citing works
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Vilhjálmsson, B. J., Yang, J., Finucane, H. K., Gusev, A., Lindström, S., Ripke, S., Genovese, G., Loh, P.-R., Bhatia, G., Do, R., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.09.001 · Cited by 1,303 · see citing works
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941 · see citing works
Penninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839 · see citing works
Self-citationLamers, F., Vogelzangs, N., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.144 · Cited by 691 · see citing works
Human Leptin Levels Are Pulsatile and Inversely Related to Pituitary–Ardenal Function
Licinio, J., Mantzoros, C., Negrão, A. B., Cizza, G., Wong, M.-L., Bongiorno, P. B., Chrousos, G. P., Karp, B., Allen, C., Flier, J. S., et al. (1997) · Nature Medicine · doi:10.1038/nm0597-575 · Cited by 632 · see citing works
Dehghan, A., Dupuis, J., Barbalić, M., Bis, J. C., Eiríksdóttir, G., Lu, C., Pellikka, N., Wallaschofski, H., Kettunen, J., Henneman, P., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.948570 · Cited by 512 · see citing works
The Hunger Genes: Pathways to Obesity
van der Klaauw, A. A., & Farooqi, I. S. (2015) · Cell · doi:10.1016/j.cell.2015.03.008 · Cited by 393 · see citing works
Cytokines and Glucocorticoid Receptor Signaling
Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339 · see citing works
A Better Coefficient of Determination for Genetic Profile Analysis
Lee, S., Goddard, M. E., Wray, N. R., & Visscher, P. M. (2012) · Genetic Epidemiology · doi:10.1002/gepi.21614 · Cited by 338 · see citing works
Induction of leptin resistance through direct interaction of C-reactive protein with leptin
Chen, K., Li, F., Li, J., Cai, H., Strom, S., Bisello, A., Kelley, D. E., Friedman-Einat, M., Skibinski, G. A., McCrory, M. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1372 · Cited by 325 · see citing works
MIDDELDORP, C. M., CATH, D. C., VAN DYCK, R., & BOOMSMA, D. I. (2005) · Psychological Medicine · doi:10.1017/s003329170400412x · Cited by 316 · see citing works
Self-citationThe leptin hypothesis of depression: a potential link between mood disorders and obesity?
Lu, X.-Y. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.010 · Cited by 303 · see citing works
Adjusting for Heritable Covariates Can Bias Effect Estimates in Genome-Wide Association Studies
Aschard, H., Vilhjálmsson, B. J., Joshi, A. D., Price, A. L., & Kraft, P. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.12.021 · Cited by 287 · see citing works
Lamers, F., de Jonge, P., Nolen, W. A., Smit, J. H., Zitman, F. G., Beekman, A. T. F., & Penninx, B. W. J. H. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05398blu · Cited by 264 · see citing works
Self-citationThe meta-analysis of genome-wide association studies
Thompson, J. R., Attia, J., & Minelli, C. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr020 · Cited by 250 · see citing works
Impaired CNS Leptin Action Is Implicated in Depression Associated with Obesity
Yamada, N., Katsuura, G., Ochi, Y., Ebihara, K., Kusakabe, T., Hosoda, K., & Nakao, K. (2011) · Endocrinology · doi:10.1210/en.2011-0004 · Cited by 247 · see citing works
Simmons, W. K., Burrows, K., Avery, J. A., Kerr, K. L., Bodurka, J., Savage, C. R., & Drevets, W. C. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020162 · Cited by 245 · see citing works
Lasserre, A., Glaus, J., Vandeleur, C., Marques-Vidal, P., Vaucher, J., Bastardot, F., Waeber, G., Vollenweider, P., & Preisig, M. (2014) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2014.411 · Cited by 232 · see citing works
Novick, J. S., Stewart, J. W., Wisniewski, S. R., Cook, I. A., Manev, R. M., Nierenberg, A. A., Rosenbaum, J. F., Shores‐Wilson, K., Balasubramani, G. K., Biggs, M. M., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0807 · Cited by 211 · see citing works
Garza, J. C., Guo, M., Zhang, W., & Lu, X.-Y. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.161 · Cited by 209 · see citing works
Milaneschi, Y., Lamers, F., Bot, M., Drent, M. L., & Penninx, B. W. J. H. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.023 · Cited by 209 · see citing works
Metabolic and inflammatory markers: associations with individual depressive symptoms
Lamers, F., Milaneschi, Y., de Jonge, P., Giltay, E. J., & Penninx, B. W. J. H. (2017) · Psychological Medicine · doi:10.1017/s0033291717002483 · Cited by 197 · see citing works
The associations between psychopathology and being overweight: a 20-year prospective study
Hasler, G., Pine, D. S., Gamma, A., Milos, G. F., Ajdacic‐Gross, V., Eich, D., Wulf Rössler, A., & Angst, J. (2004) · Psychological Medicine · doi:10.1017/s0033291703001697 · Cited by 192 · see citing works
Palla, L., & Dudbridge, F. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.06.005 · Cited by 185 · see citing works
Polygenic dissection of major depression clinical heterogeneity
Milaneschi, Y., Lamers, F., Peyrot, W. J., Abdellaoui, A., Willemsen, G. A. H. M., Hottenga, J., Jansen, R., Mbarek, H., Dehghan, A., Lu, C., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.86 · Cited by 183 · see citing works
Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels
Kilpeläinen, T. O., Carli, J. F. M., Skowronski, A. A., Sun, Q., Kriebel, J., Feitosa, M. F., Hedman, Å. K., Drong, A., Hayes, J. E., Zhao, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10494 · Cited by 180 · see citing works
Neurodevelopmental actions of leptin
Bouret, S. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.04.011 · Cited by 178 · see citing works
Genetic pleiotropy in complex traits and diseases: implications for genomic medicine
Gratten, J., & Visscher, P. M. (2016) · Genome Medicine · doi:10.1186/s13073-016-0332-x · Cited by 176 · see citing works
Kaestner, F., Hettich, M., Peters, M., Sibrowski, W., Hetzel, G., Ponath, G. D., Arolt, V., Cassens, U., & Rothermundt, M. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.03.012 · Cited by 174 · see citing works
The subtypes of major depression in a twin registry
Sullivan, P. F., Prescott, C. A., & Kendler, K. S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00364-5 · Cited by 146 · see citing works
Farr, O. M., Tsoukas, M. A., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.004 · Cited by 146 · see citing works
Xu, Q., Anderson, D., & Lurie-Beck, J. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.04.007 · Cited by 136 · see citing works
Ring, L. E., & Zeltser, L. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41985 · Cited by 115 · see citing works
Lasserre, A. M., Strippoli, M. F., Glaus, J., Gholam‐Rezaee, M., Vandeleur, C. L., Castelao, E., Marques-Vidal, P. M., Waeber, G., Vollenweider, P., & Preisig, M. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.178 · Cited by 112 · see citing works
Selective deletion of leptin receptors in adult hippocampus induces depression-related behaviours
Guo, M., Huang, T.-Y., Garza, J. C., Chua, S. C., & Lu, X. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000703 · Cited by 101 · see citing works
Direction of Weight Change in Recurrent Depression
Stunkard, A. J. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810210065009 · Cited by 95 · see citing works
Six-year longitudinal course and outcomes of subtypes of depression
Lamers, F., Beekman, A. T. F., van Hemert, A. M., Schoevers, R. A., & Penninx, B. W. J. H. (2015) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.153098 · Cited by 94 · see citing works
Stability and transitions of depressive subtypes over a 2-year follow-up
Lamers, F., Rhebergen, D., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2012) · Psychological Medicine · doi:10.1017/s0033291712000141 · Cited by 88 · see citing works
Cizza, G., Ronsaville, D. S., Kleitz‐Nelson, H. K., Eskandari, F., Mistry, S., Torvik, S., Sonbolian, N., Reynolds, J. C., Blackman, M. R., Gold, P. W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028912 · Cited by 85 · see citing works
Depressive disorder moderates the effect of the FTO gene on body mass index
Rivera, M., Cohen‐Woods, S., Kapur, K., Breen, G. D., Ng, M. Y., Butler, A. W., Craddock, N. J., Gill, M., Korszun, A., Maier, W., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.45 · Cited by 85 · see citing works
Obesity Comorbidity in Unipolar Major Depressive Disorder
Levitan, R. D., Davis, C., Kaplan, A. S., Arenovich, T., Phillips, D. I. W., & Ravindran, A. V. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07394 · Cited by 81 · see citing works
The effect of FTO rs9939609 on major depression differs across MDD subtypes
Milaneschi, Y., Lamers, F., Mbarek, H., Hottenga, J.-J., Boomsma, D. I., & Penninx, B. W. J. H. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.4 · Cited by 78 · see citing works
Self-citationRudolf, S., Greggersen, W., Kahl, K. G., Hüppe, M., & Schweiger, U. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.02.016 · Cited by 71 · see citing works
Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals
Rivera, M., Locke, A. E., Corre, T., Czamara, D., Wolf, C., Ching-López, A., Milaneschi, Y., Kloiber, S. M., Cohen‐Woods, S., Rucker, J., et al. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.116.183475 · Cited by 66 · see citing works
Guo, M., & Lu, X.-Y. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.126 · Cited by 55 · see citing works
The association between leptin and depressive symptoms is modulated by abdominal adiposity
Milaneschi, Y., Sutin, A. R., Terracciano, A., Canepa, M., Gravenstein, K. S., Egan, J. M., Vogelzangs, N., Guralnik, J. M., Bandinelli, S., Penninx, B. W. J. H., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.12.015 · Cited by 50 · see citing works
Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes?
Nierenberg, A. A., Pava, J. A., Clancy, K., Rosenbaum, J. F., & D, M. F. M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(96)00029-7 · Cited by 36 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Depression and obesity: evidence of shared biological mechanisms
Milaneschi, Y., Simmons, W. K., van Rossum, E. F. C., & Penninx, B. W. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0017-5 · Cited by 1,073 · see citing works
“Recent large-scale analyses [31] involving >25,000 samples reported a strong genetic correlation (0.”
BackgroundInfluentialComorbid depression in medical diseases
Gold, S. M., Köhler‐Forsberg, O., Moss-Morris, R. E., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0200-2 · Cited by 547 · see citing works
The menace of obesity to depression and anxiety prevalence
Fulton, S., Décarie-Spain, L., Fioramonti, X., Guiard, B., & Nakajima, S. (2022) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.10.005 · Cited by 441 · see citing works
“Obese individuals, particularly those presenting attributes of metabolic syndrome (abdominal obesity, hyperglycemia, hypertension, elevated triglycerides), tend to develop the atypical subtype [9] (Box 1).”
BackgroundDepression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression
Milaneschi, Y., Lamers, F., Berk, M., & Penninx, B. W. J. H. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.014 · Cited by 433 · see citing works
Machine learning in major depression: from classification to treatment outcome prediction
Gao, S., Calhoun, V. D., & Sui, J. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13048 · Cited by 370 · see citing works
Milaneschi, Y., Kappelmann, N., Ye, Z., Lamers, F., Moser, S., Jones, P. B., Burgess, S., Penninx, B. W. J. H., & Khandaker, G. M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01188-w · Cited by 371 · see citing works
Kappelmann, N., Arloth, J., Georgakis, M. K., Czamara, D., Rost, N., Ligthart, S., Khandaker, G. M., & Binder, E. B. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3436 · Cited by 262 · see citing works
Bot, M., Milaneschi, Y., Alshehri, T., Amin, N., Garmaeva, S., Onderwater, G. L. J., Pool, R., Thesing, C. S., Vijfhuizen, L. S., Vogelzangs, N., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.08.016 · Cited by 241 · see citing works
Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder
Chan, K. L., Cathomas, F., & Russo, S. J. (2019) · Physiology · doi:10.1152/physiol.00047.2018 · Cited by 227 · see citing works
The genetic basis of major depression
Kendall, K. M., Van Assche, E., Andlauer, T. F. M., Choi, K. W., Luykx, J. J., Schulte, E. C., & Lu, Y. (2021) · Psychological Medicine · doi:10.1017/s0033291721000441 · Cited by 213 · see citing works
“However, a trans-ancestry meta-analysis conducted within the same study increased the number of risk loci from 178 in Europeans alone to 183.”
BackgroundInfluentialUncovering the Genetic Architecture of Major Depression
McIntosh, A. M., Sullivan, P. F., & Lewis, C. M. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.022 · Cited by 160 · see citing works
Insulin resistance in depression: A large meta-analysis of metabolic parameters and variation
Fernandes, B. S., Salagre, E., Enduru, N., Grande, I., Vieta, E., & Zhao, Z. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104758 · Cited by 161 · see citing works
Cai, N., Choi, K. W., & Fried, E. I. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa115 · Cited by 153 · see citing works
“Conversely, PRS for immune-metabolic traits such as body mass index (BMI) and C-reactive protein are strongly associated with the atypical depression (24), and patients with the atypical subtype were found to carry more genetic risk variants for BMI and C-reactive protein (25).”
BackgroundDepression profilers and immuno-metabolic dysregulation: longitudinal results from the NESDA study.
Lamers, F., Milaneschi, Y., Vinkers, C., Schoevers, R., Giltay, E., & Penninx, B. (2020) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2020.04.002 · Cited by 139 · see citing works
Li, Y., Cheng, Y., Zhou, Y., Du, H., Zhang, C., Zhao, Z., Chen, Y., Zhou, Z., Mei, J., Wu, W., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113949 · Cited by 150 · see citing works
Chu, A. L., Štochl, J., Lewis, G., Zammit, S., Jones, P. B., & Khandaker, G. M. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.007 · Cited by 136 · see citing works
Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders
Bahrami, S., Steen, N. E., Shadrin, A. A., O’Connell, K. S., Frei, O., Bettella, F., Wirgenes, K. V., Krull, F., Fan, C. C., Dale, A. M., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.4188 · Cited by 132 · see citing works
Genetic heterogeneity and subtypes of major depression
Nguyen, T.-D., Harder, A., Xiong, Y., Kowalec, K., Hägg, S., Cai, N., Kuja-Halkola, R., Dalman, C., Sullivan, P. F., & Lu, Y. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01413-6 · Cited by 129 · see citing works
Immuno-metabolic depression: from concept to implementation
Penninx, B. W. J. H., Lamers, F., Jansen, R., Berk, M., Khandaker, G. M., Picker, L. D., & Milaneschi, Y. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101166 · Cited by 126 · see citing works
The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders
Jones, D. N., & Raghanti, M. A. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.101957 · Cited by 116 · see citing works
Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
Morris, G., Puri, B. K., Walker, A. J., Maes, M. H. J., Carvalho, A. F., Bortolasci, C. C., Walder, K. R., & Berk, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.025 · Cited by 112 · see citing works
Postolache, T. T., del Bosque‐Plata, L., Jabbour, S. A., Vergare, M. J., Wu, R., & Gragnoli, C. (2019) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32712 · Cited by 107 · see citing works
“The authors concluded that the association may derive from shared immune-metabolic dysregulations (Milaneschi et al., 2017).”
BackgroundThe genetics of depression: successful genome-wide association studies introduce new challenges
Ormel, J., Hartman, C. A., & Snieder, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0450-5 · Cited by 107 · see citing works
Depression and Obesity: Analysis of Common Biomarkers
Milano, W., Ambrosio, P., Carizzone, F., Biasio, V. D., Munzio, W. D., Foia, M. G., & Capasso, A. (2020) · Diseases · doi:10.3390/diseases8020023 · Cited by 107 · see citing works
“Epidemiological evidence has identified solid associations between depression and obesity [1].”
BackgroundMetabolomic and inflammatory signatures of symptom dimensions in major depression
Brydges, C. R., Bhattacharyya, S., Dehkordi, S. M., Milaneschi, Y., Penninx, B., Jansen, R., Kristal, B. S., Han, X., Arnold, M., Kastenmüller, G., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.02.003 · Cited by 108 · see citing works
Jokela, M., & Laakasuo, M. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.05.034 · Cited by 101 · see citing works
Brăilean, A., Curtis, J., Davis, K. A. S., Dregan, A., & Hotopf, M. H. (2019) · Psychological Medicine · doi:10.1017/s0033291719001004 · Cited by 94 · see citing works
Kong, L., Nilsson, I. A. K., Brismar, K., Gissler, M., & Lavebratt, C. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20787 · Cited by 89 · see citing works
Frank, P., Jokela, M. M., Batty, G. D., Lassale, C. M., Steptoe, A., & Mika Kivimaki, B. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.07.009 · Cited by 89 · see citing works
Obesity in Adolescents with Psychiatric Disorders
Chao, A. M., Wadden, T. A., & Berkowitz, R. I. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-0990-7 · Cited by 84 · see citing works
Functional Connectivity of the Nucleus Accumbens and Changes in Appetite in Patients With Depression
Kroemer, N. B., Opel, N., Teckentrup, V., Li, M., Grotegerd, D., Meinert, S. L., Lemke, H., Kircher, T. T. J., Nenadić, I., Krug, A., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.2464 · Cited by 81 · see citing works
Badini, I., Coleman, J. R. I., Hagenaars, S. P., Hotopf, M. H., Breen, G. D., Lewis, C. M., & Fabbri, C. (2020) · Psychological Medicine · doi:10.1017/s0033291720002342 · Cited by 74 · see citing works
“%) to estimate heritability considering an expected heritability of 0.10 (Milaneschi et al., 2017), using GCTA-GREML Power Calculator (Visscher et al., 2014).”
BackgroundMethodResultInfluentialMilaneschi, Y., Allers, K. A., Beekman, A. T. F., Giltay, E. J., Keller, S., Schoevers, R. A., Süßmuth, S. D., Niessen, H. G., & Penninx, B. W. J. H. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.007 · Cited by 70 · see citing works
“15 contrast, genetic signature of inflammatory and metabolic alterations characterize specifically atypical-like depressive symptoms(38,39), linked in the present study to increased KYN and QUIN levels.”
Sen, Z. D., Danyeli, L. V., Woelfer, M., Lamers, F., Wagner, G., Sobanski, T., & Walter, M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.12.020 · Cited by 65 · see citing works
Self-citationLifetime and current depression in the German National Cohort (NAKO)
Streit, F., Zillich, L., Frank, J., Kleineidam, L., Wagner, M., Baune, B. T., Klinger-König, J., Grabe, H. J., Pabst, A., Riedel-Heller, S. G., et al. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.2014152 · Cited by 64 · see citing works
“Furthermore, specific definitions, subtypes and aspects of depression may differ in their underlying neurobiology (Milaneschi et al. 2017; Cai et al. 2020; Hagenaars et al. 2020), stressing the need for comprehensive phenotypic assessment.”
BackgroundHagenaars, S. P., Coleman, J. R. I., Choi, S. W., Gaspar, H., Adams, M. J., Howard, D. M., Hodgson, K., Traylor, M., Air, T. M., Andlauer, T. F. M., et al. (2020) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32807 · Cited by 61 · see citing works
Self-citationPistis, G., Milaneschi, Y., Vandeleur, C. L., Lasserre, A. M., Penninx, B. W. J. H., Lamers, F., Boomsma, D. I., Hottenga, J., Marques-Vidal, P. M., Vollenweider, P., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01236-7 · Cited by 58 · see citing works
Kappelmann, N., Czamara, D., Rost, N., Moser, S., Schmoll, V., Trastulla, L., Štochl, J., Lucae, S., Binder, E. B., Khandaker, G. M., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.03.024 · Cited by 58 · see citing works
Mitchell, B. L., Campos, A. I., Whiteman, D. C., Olsen, C. M., Gordon, S. D., Walker, A. J., Dean, O. M., Berk, M., Hickie, I. B., Medland, S. E., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.10.021 · Cited by 47 · see citing works
Ten challenges for clinical translation in psychiatric genetics
Derks, E. M., Thorp, J. G., & Gerring, Z. F. (2022) · Nature Genetics · doi:10.1038/s41588-022-01174-0 · Cited by 54 · see citing works
Ellul, P., Mariotti‐Ferrandiz, E., Leboyer, M., & Klatzmann, D. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00167 · Cited by 51 · see citing works
Lin, D., Wang, L., Yan, S., Zhang, Q., Zhang, J. H., & Shao, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2491927 · Cited by 51 · see citing works
“The former involves factors like poor financial situation, marital status, and life events; the latter have genetic and gender predisposition and other health conditions like obesity [21] and diabetes [22].”
Backgroundde Wit, L. M., ten Have, M., Cuijpers, P. J., & de Graaf, R. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04077-w · Cited by 53 · see citing works
A role for vitamin D and omega-3 fatty acids in major depression? An exploration using genomics
Milaneschi, Y., Peyrot, W. J., Nivard, M. G., Mbarek, H., Boomsma, D. I., & Penninx, B. W. J. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0554-y · Cited by 46 · see citing works
Genetic stratification of depression by neuroticism: revisiting a diagnostic tradition
Adams, M. J., Howard, D. M., Luciano, M., Clarke, T., Davies, G., Hill, W. D., Smıth, D. J., Deary, I. J., Porteous, D. J., & McIntosh, A. M. (2019) · Psychological Medicine · doi:10.1017/s0033291719002629 · Cited by 47 · see citing works
Metabolomics signatures of depression: the role of symptom profiles
de Kluiver, H., Jansen, R., Penninx, B., Giltay, E., Schoevers, R., & Milaneschi, Y. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02484-5 · Cited by 41 · see citing works
“Large-scale genomic studies [14, 15] identified shared genetic liabilities between symptoms of hyperphagia, hypersomnia and weight gain during a depressive episode and traits such as elevated CRP, leptin, and body mass index (BMI), partially explaining their phenotypic connection.”
BackgroundResultMajor depression and enhanced molecular senescence abnormalities in young and middle-aged adults
Diniz, B. S., Reynolds, C. F., Sibille, E. L., Bot, M., & Penninx, B. W. J. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0541-3 · Cited by 45 · see citing works
Fabbri, C., Pain, O., Hagenaars, S. P., Lewis, C. M., & Serretti, A. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01059-6 · Cited by 46 · see citing works
Chu, K., Cadar, D., Iob, E., & Frank, P. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.11.016 · Cited by 47 · see citing works
Polygenic Scores in Psychiatry: On the Road From Discovery to Implementation
Lewis, C. M., & Vassos, E. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220795 · Cited by 44 · see citing works
Alshehri, T., Boone, S. C., de Mutsert, R., Penninx, B. W. J. H., Rosendaal, F. R., le Cessie, S., Milaneschi, Y., & Mook-Kanamori, D. O. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104429 · Cited by 44 · see citing works
Perry, B. I., Khandaker, G. M., Marwaha, S., Thompson, A., Zammit, S., Singh, S. P., & Upthegrove, R. (2020) · Psychological Medicine · doi:10.1017/s0033291719000308 · Cited by 42 · see citing works
“Taken together with previous research (Khandaker et al., 2014; Miller and Raison, 2016; Khandaker et al., 2018a) which suggests that immune dysfunction could be a target for prevention and treatment of depression, our findings may suggest that other factors also play an important role in increasing…”
ResultMocking, R. J. T., Naviaux, J. C., Li, K., Wang, L., Monk, J. M., Bright, A. T., Figueroa, C. A., Schene, A. H., Ruhé, H. G., Assies, J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01182-w · Cited by 40 · see citing works
Toenders, Y. J., Schmaal, L., Harrison, B. J., Dinga, R., Berk, M., & Davey, C. G. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0787-9 · Cited by 39 · see citing works
“In addition, genetic studies have shown that the atypical subtype with increased appetite is associated with a higher polygenic risk score for BMI, leptin and CRP, whereas the typical subtype showed a stronger association with polygenic risk scores for psychiatric disorders such as schizophrenia (24, 25).”
BackgroundÇakici, N., Sutterland, A. L., Penninx, B. W. J. H., de Haan, L., & van Beveren, N. J. M. (2021) · Psychological Medicine · doi:10.1017/s0033291721000155 · Cited by 38 · see citing works
Xu, Z., Zhang, S., Huang, L., Zhu, X., Zhao, Q., Zeng, Y., Zhou, D., Wang, D., Kuga, H., Kamiya, A., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00195 · Cited by 38 · see citing works
Chauvet‐Gélinier, J., Roussot, A., Cottenet, J., Brindisi, M., Petit, J., Bonin, B., Vergès, B. L., & Quantin, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210507 · Cited by 38 · see citing works
“Recent studies have indicated that specific genotypes might contribute to atypical depression features with an associated risk of overweight and obesity, suggesting the relationship between depression and obesity may require special attention to prevent comorbid conditions [14,15].”
BackgroundÇakici, N., Bot, M., Lamers, F., Janssen, T., van der Spek, P. J., de Haan, L., Bahn, S., Penninx, B. W. J. H., & van Beveren, N. J. M. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.05.010 · Cited by 37 · see citing works
Peripheral Inflammatory Markers in Subtypes and Core Features of Depression: A Systematized Review
Křenek, P., Hořínková, J., & Bartečků, E. (2023) · Psychopathology · doi:10.1159/000528907 · Cited by 35 · see citing works
Calcaterra, V., Rossi, V., Magenes, V. C., Baldassarre, P., Grazi, R., Loiodice, M., Fabiano, V., & Zuccotti, G. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1368283 · Cited by 40 · see citing works
Stapelberg, N. J. C., Neumann, D. L., Shum, D., & Headrick, J. P. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.10.014 · Cited by 35 · see citing works
Interventions targeting comorbid depression and overweight/obesity: A systematic review
Cao, B., Xu, J., Li, R., Teopiz, K. M., McIntyre, R. S., & Chen, H. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.027 · Cited by 32 · see citing works
Ikeda, M., Tanaka, S., Saito, T., Ozaki, N., Kamatani, Y., & Iwata, N. (2018) · Psychological Medicine · doi:10.1017/s0033291718000685 · Cited by 31 · see citing works
“In contrast, more typical features of MDD (decreased appetite and body weight, probably including melancholia) exhibited a nonsignificant trend of negative correlation with BMI (rg = −0.28, p = 0.06; Milaneschi et al. 2017).”
BackgroundInfluentialOpel, N., Redlich, R., Repple, J., Flint, C., Grotegerd, D., Dohm, K., Zaremba, D., Goltermann, J., Steinmann, L. A., Krughöfer, R., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.027 · Cited by 30 · see citing works
Fabbri, C., Montgomery, S., Lewis, C. M., & Serretti, A. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000305 · Cited by 32 · see citing works
Refisch, A., Şen, Z. D., Klassert, T. E., Busch, A., Besteher, B., Danyeli, L. V., Helbing, D. L., Schulze‐Späte, U., Stallmach, A., Bauer, M. W., et al. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109568 · Cited by 30 · see citing works
The effects of ketamine on typical and atypical depressive symptoms
Park, L. T., Luckenbaugh, D. A., Pennybaker, S. J., Hopkins, M., Henter, I. D., Lener, M. S., Kadriu, B., Ballard, E. D., & Zarate, C. A. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13216 · Cited by 30 · see citing works
Reduced mitochondrial respiration in T cells of patients with major depressive disorder
Gamradt, S., Hasselmann, H., Taenzer, A., Brasanac, J., Stiglbauer, V., Sattler, A., Sajitz-Hermstein, M., Kierszniowska, S., Ramien, C., Nowacki, J., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103312 · Cited by 29 · see citing works
“Given the importance of inflammation in the pathophysiology of MDD (Miller and Raison, 2016) and the crucial role of metabolic programming for immunity (Buck et al., 2017), it seems biologically plausible that metabolic dysfunction in general, and altered immunometabolism in particular, could…”
BackgroundNolde, M., Holtfreter, B., Kocher, T., Alayash, Z., Reckelkamm, S. L., Ehmke, B., Baurecht, H., & Baumeister, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.918404 · Cited by 29 · see citing works
“Intriguingly, the genetic susceptibility for depression is highly correlated with the polygenic risk for systemic inflammation, providing a putative biological pathway for the association with periodontal disease (9).”
BackgroundSchwabe, I., Milaneschi, Y., Gerring, Z. F., Sullivan, P. F., Schulte, E. C., Suppli, N. P., Thorp, J. G., Derks, E. M., & Middeldorp, C. M. (2019) · Psychological Medicine · doi:10.1017/s0033291719002502 · Cited by 29 · see citing works
“…of the PGC, rg between early-onset and late-onset MDD was approximately 0.99 (Power et al., 2017), and around 0.82 between MDD patients with atypical symptoms of increased appetite and/or weight and those with more typical symptoms of decreased appetite and/or weight (Milaneschi et al., 2017).”
BackgroundInfluentialMac Giollabhui, N., Alloy, L. B., Schweren, L. J. S., & Hartman, C. A. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.05.022 · Cited by 25 · see citing works
Weissman, M. M. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.0954 · Cited by 27 · see citing works
Chae, W. R., Nübel, J., Baumert, J., Gold, S. M., & Otte, C. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.04.024 · Cited by 29 · see citing works
Chae, W. R., Baumert, J., Nübel, J., Brasanac, J., Gold, S. M., Hapke, U., & Otte, C. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.03.007 · Cited by 27 · see citing works
Involvement of inflammatory gene expression pathways in depressed patients with hyperphagia
de Kluiver, H., Jansen, R., Milaneschi, Y., & Penninx, B. W. J. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0528-0 · Cited by 26 · see citing works
Stability and transition of depression subtypes in late life
Veltman, E. M., Kok, A. A. L., Lamers, F., Stek, M. L., van der Mast, R. C., & Rhebergen, D. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.049 · Cited by 25 · see citing works
The associations of self-rated health with cardiovascular risk proteins: a proteomics approach
Bao, X., Borné, Y., Yin, S., Niu, K., Orho‐Melander, M., Nilsson, J. Å., Melander, O., & Engström, G. (2019) · Clinical Proteomics · doi:10.1186/s12014-019-9258-9 · Cited by 24 · see citing works
Kokkeler, K. J. E., Marijnissen, R. M., Wardenaar, K. J., Rhebergen, D., van den Brink, R. H. S., van der Mast, R. C., & Voshaar, R. C. O. (2020) · Psychological Medicine · doi:10.1017/s0033291720002159 · Cited by 24 · see citing works
“In adult depressed patients an association between atypical depression and metabolic-inflammatory dysregulation was found (Lamers et al., 2013; Milaneschi et al., 2017; Vogelzangs et al., 2014a, 2014b), nevertheless previous findings in older depressed patients were not consistent (Veltman et al.,…”
ResultFrankel, R. A., Michels, K. A., Kim, K., Kuhr, D. L., Omosigho, U. R., Wactawski‐Wende, J., Levine, L. D., Perkins, N. J., & Mumford, S. L. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01187-7 · Cited by 25 · see citing works
Metabolomics dissection of depression heterogeneity and related cardiometabolic risk
Alshehri, T., Mook‐Kanamori, D. O., van Dijk, K. W., Dinga, R., Penninx, B. W. J. H., Rosendaal, F. R., le Cessie, S., & Milaneschi, Y. (2021) · Psychological Medicine · doi:10.1017/s0033291721001471 · Cited by 25 · see citing works
“Interestingly, earlier (Milaneschi et al., 2017b) and recent (Badini et al., 2020) large-scale genomic studies found that the genetic overlap between BMI, CRP and leptin with depression is symptom specific; this overlap was only found in depressed patients with increased hypersomnia (Badini et al.,…”
BackgroundAssociations of polygenic risks, depression, and obesity-related traits in Taiwan Biobank
Liao, S.-F., Su, C.-Y., Su, M., Chen, C., Chen, C., Lin, K., Pan, Y., Hsiao, P., Chen, P., Huang, Y., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.149 · Cited by 24 · see citing works
Adams, M. J., Thorp, J. G., Jermy, B. S., Kwong, A. S. F., Kõiv, K., Grotzinger, A. D., Nivard, M. G., Marshall, S., Milaneschi, Y., Baune, B. T., et al. (2024) · Psychological Medicine · doi:10.1017/s0033291724001880 · Cited by 27 · see citing works
“However, a positive genetic correlation between increase in appetite/weight with BMI has previously been shown with PGC cohorts (Milaneschi et al., 2017) and in UKB (Badini et al., 2022), and our findings show that this result holds even when adjusting for genetic overlap with other symptoms.”
ResultDissection of depression heterogeneity using proteomic clusters
van Haeringen, M., Milaneschi, Y., Lamers, F., Penninx, B. W. J. H., & Jansen, R. (2022) · Psychological Medicine · doi:10.1017/s0033291721004888 · Cited by 22 · see citing works
Prenatal and Childhood Immuno-Metabolic Risk Factors for Adult Depression and Psychosis
Kappelmann, N., Perry, B. I., & Khandaker, G. M. (2022) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000322 · Cited by 22 · see citing works
The association between trauma exposure, polygenic risk and individual depression symptoms
Thorp, J. G., Gerring, Z. F., Colodro‐Conde, L., Byrne, E. M., Medland, S. E., Middeldorp, C. M., & Derks, E. M. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115101 · Cited by 23 · see citing works
Obesity and Depression: A Pathophysiotoxic Relationship
Monsalve, F. A., Fernández-Tapia, B., Arriagada, O., González, D. R., & Delgado‐López, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311590 · Cited by 22 · see citing works
“Obesity and depression are two of the most prevalent diseases worldwide and represent significant problems, not only due to their direct impact on people’s health and well-being but also due to their socioeconomic repercussions [1].”
Perry, B. I., Oltean, B. P., Jones, P. B., & Khandaker, G. M. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104682 · Cited by 21 · see citing works
Milaneschi, Y., Lamers, F., & Penninx, B. W. J. H. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.4373 · Cited by 21 · see citing works
Deal, A. W., Seshie, O., Lenzo, A., Cooper, N., Ozimek, N., & Woods, L. C. S. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00018.2020 · Cited by 20 · see citing works
Strawbridge, R., Johnston, K., Bailey, M. E. S., Baldassarre, D., Cullen, B., Eriksson, P., Defaire, U., Ferguson, A., Gigante, B., Giral, P., et al. (2020) · medRxiv · doi:10.1038/s41598-020-79964-x · Cited by 21 · see citing works
Palmos, A., Hübel, C., Lim, K. X., Hunjan, A. K., Coleman, J. R. I., & Breen, G. D. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.01.003 · Cited by 18 · see citing works
“Although previous studies have shown genetic associations between MDD and increased or decreased appetite and weight (68), as well as between MDD and increased weight gain and hypersomnia (69), to our knowledge, this is the first study to investigate the bidirectional association between BMI, MDD, CRP, and childhood t…”
ResultA multivariate genome-wide association study of psycho-cardiometabolic multimorbidity
Baltramonaityte, V., Pingault, J., Cecil, C. A. M., Choudhary, P., Järvelin, M., Penninx, B. W. J. H., Felix, J. F., Sebert, S. P., Milaneschi, Y., & Walton, E. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010508 · Cited by 19 · see citing works
Testing Bidirectional Associations Between Childhood Aggression and BMI: Results from Three Cohorts
Derks, I. P. M., Bolhuis, K., Yalcin, Z., Gaillard, R., Hillegers, M. H. J., Larsson, H., Lundström, S., Lichtenstein, P., van Beijsterveldt, C. E. M., Bartels, M., et al. (2019) · Obesity · doi:10.1002/oby.22419 · Cited by 17 · see citing works
“sive symptoms and obesity (38), and this could potentially also apply to other psychiatric problems such as aggressive behavior, which are (genetically) related to depressed mood (39,40).”
BackgroundGolds, L., de Kruiff, K., & MacBeth, A. M. (2019) · Development and Psychopathology · doi:10.1017/s0954579419000142 · Cited by 19 · see citing works
Fabbri, C., & Serretti, A. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.4.484 · Cited by 18 · see citing works
“body max index (BMI), and triglycerides [7-9].”
BackgroundWu, S., Zhou, Y.-F., Xuan, Z.-Z., Xiong, L., Ge, X., Ye, J.-R., Liu, Y., Yuan, L., Xu, Y., Ding, G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92807-7 · Cited by 14 · see citing works
van Loo, H. M., Aggen, S. H., & Kendler, K. S. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.03.064 · Cited by 17 · see citing works
The Co-occurrence of Depression and Obesity
McIntyre, R. S. (2024) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.24com15322 · Cited by 17 · see citing works
Exploring the Bidirectional Relationship Between Depression and Obesity
Park, S., Kato, T. A., Lee, J.-H., & Yu, S. H. (2025) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.10.010 · Cited by 17 · see citing works
Fourrier, C., Sampson, E., Hori, H., Schubert, K. O., Clark, S. R., Mills, N. T., & Baune, B. T. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.06.007 · Cited by 16 · see citing works
- Authors
- Milaneschi, Y., Lamers, F., Peyrot, W. J., Baune, B. T., Breen, G., Dehghan, A., Forstner, A. J., Grabe, H. J., Homuth, G., Kan, C., Lewis, C., Mullins, N., Nauck, M., Pistis, G., Preisig, M., Rivera, M., Rietschel, M., Streit, F., Strohmaier, J., Teumer, A., Van der Auwera, S., Wray, N. R., Boomsma, D. I., Penninx, B. W. J. H., & for the CHARGE Inflammation Working Group and the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
- Affiliations
- Amsterdam Neuroscience (NL)
- The University of Adelaide (AU)
- King's College London (GB)
- Imperial College London (GB)
- University of Bonn (DE)
- Universitätsmedizin Greifswald (DE)
- Centre Hospitalier Universitaire Vaudois (CH)
- Universidad de Granada (ES)
- Heidelberg University (DE)
- Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany
- The University of Queensland (AU)
- Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Milaneschi, Yuri
- ORCID
- Milaneschi, Yuri
- Lamers, Femke
- Peyrot, Wouter J.
- Baune, Bernhard T.
- Breen, Gerome
- Dehghan, Abbas
- Grabe, Hans J.
- Homuth, Georg
- Kan, Carol
- Lewis, Cathryn
- Mullins, Niamh
- Pistis, Giorgio
- Preisig, Martin
- Rivera, Margarita
- Rietschel, Marcella
- Streit, Fabian
- Strohmaier, Jana
- Teumer, Alexander
- Wray, Naomi R.
- Boomsma, Dorret I.
- Penninx, Brenda W. J. H.
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2017-12-01
- Volume
- 74
- Issue
- 12
- Pages
- 1214
- ISSN
- 2168-622X (ISSN-L)
- PMC
- PMC6396812
- OpenAlex
- W2766503838
- Cited by
- 233
- References
- 56
- Citations by year
- 2026: 15 · 2025: 30 · 2024: 15 · 2023: 29 · 2022: 33 · 2021: 41 · 2020: 31 · 2019: 29 · 2018: 9 · 2017: 1
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Psychiatry (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- VU Research Portal (publishedVersion, other-oa)
- ResearchOnline - JCU (James Cook University) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- IRIS (submittedVersion)
- Iris (University of Trento) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- National Science Foundation (33CS30-139468, 33CS30-148401, 33CSCO-122661)
- Foundation for the National Institutes of Health (1RC2 MH089995)
- Amgen
- Pfizer
- GlaxoSmithKline (3200B0–105993, 33CSCO-122661, 3200B0-118308, 33CS30-148401, 33CS30-139468)
- Brigham and Women's Hospital
- Massachusetts General Hospital
- University of Southern California
- Kaiser Permanente
- Massachusetts Institute of Technology
- Emory University
- F. Hoffmann-La Roche
- Washington University in St. Louis
- Aarhus Universitet
- Aarhus Universitetshospital
- Johns Hopkins University
- University of Texas Southwestern Medical Center
- Universität Basel
- Virginia Commonwealth University
- South London and Maudsley NHS Foundation Trust
- Wellcome Trust (104036/Z/14/Z)
- QIMR Berghofer Medical Research Institute
- Broad Institute
- Universitätsmedizin Göttingen
- National Institute for Health and Care Research (CL-2017-17-003)
- King's College London
- University College London
- University of Oxford
- Newcastle University
- European Commission (QLG2-CT-2002-01254, LSHB-CT-2003–503428, 503428, 230374, 01ZZ0103, 01ZZ0403, 01254, 03ZIK012, 01ZZ9603, 334065, LSHB-CT-2003)
- University of Glasgow
- Cardiff University
- Trinity College Dublin
- Deutsche Forschungsgemeinschaft (Gr1912/5‐1, 01ZZ0403, 01ZZ9603, 03ZIK012, 01ZZ0103)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (148401, 122661, 33CSCO, 118308, 105993, 230374, 3200B0, 33CS30, 139468)
- Universiteit Leiden (10‐000‐1002)
- Rijksuniversiteit Groningen (10‐000‐1002)
- Stiftelsen för Strategisk Forskning
- James Cook University
- Queensland University of Technology
- University of Queensland
- ZonMw (Middelgroot‐911‐09‐032, 56-464-14192, 184.021.007, 911‐09‐032, 1RC2 MH089995, 10‐000‐1002)
- Vrije Universiteit Amsterdam (2008.024)
- Bundesministerium für Bildung und Forschung (01ZZ9603, 01ZZ0103, and 01ZZ0403, 01ZX1314G, 01GS08147, 03ZIK012, 01ZZ0403, and 01ZZ0403, 01ZX1314D, 01GS08144, 01ZZ0103, 01ZX1314A, 01ZZ9603)
- Albert-Ludwigs-Universität Freiburg
- Gentofte Hospital
- Dalhousie University
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (184021007, 10-000-1002, 56‐464‐14192, Spinozapremie 56-464-14192)
- GGZ inGeest
- Rivierduinen
- GGZ Friesland
- GGZ Drenthe
- Nederlands Instituut voor Onderzoek van de Gezondheidszorg (10-000-1002)
- Lundbeckfonden
- University of Toronto
- Università degli Studi di Trento
- Karolinska Institutet
- Novo Nordisk
- Vetenskapsrådet (M-2005-1112)
- Westfälische Wilhelms-Universität Münster
- Leids Universitair Medisch Centrum
- Universitair Medisch Centrum Groningen
- Rigshospitalet
- Region Hovedstaden
- Háskóli Íslands
- Dokuz Eylül Üniversitesi
- Universidad de Granada
- Tartu Ülikool
- Rheinische Friedrich-Wilhelms-Universität Bonn
- Chinese Society of Clinical Oncology
- Siemens Healthineers (01ZZ0103, 01ZZ0403, 01ZZ9603)
- H. Lundbeck A/S
- Centre for Cognitive Ageing and Cognitive Epidemiology
- Universität Greifswald
- Ministry of Cultural Affairs
- National Institutes of Health (184.021.007, 389875, EU/QLRT-2001-01254, 1s10od018164-01, 1r01mh081802-01, MH66206, N01MH90003, AA13321, MH059542, AA13320, MH059541, DA12854)
- School of Medicine, Emory University
- University of North Carolina at Chapel Hill
- University of California, San Diego
- McDonnell Center for Systems Neuroscience
- Stanley Center for Psychiatric Research, Broad Institute
- Department of Psychiatry, University of Toronto
- Medical Research Council (G0701420, MR/K026992/1)
- Australian Research Council (FT0991360, FT0991022, 389875, QLG2-CT-2002-01254)
- Queensland Brain Institute
- Institute of Molecular and Cell Biology
- Statens Serum Institut
- Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg
- National Institute on Alcohol Abuse and Alcoholism (R01AA014041, R01AA007535)
- National Institute of Mental Health (MH66206, MH068457, N01‐MH‐90003, U01MH109528, MH-081802, RC2MH089995, MH089951, MH109532, U24MH068457, MH085520, R01MH060912, U01MH109532, R01MH059552, RC2MH089951, R01MH061686, MH089995, R01MH080403)
- National Institute on Drug Abuse (K08DA019951)
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK066134)
- Janssen Research and Development
- Institute of Genetics
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
- NHLBI Division of Intramural Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- major depressive disorder, atypical depression, obesity, genetic correlation, body mass index, C-reactive protein, leptin, polygenic risk, genetic overlap, Psychiatric Genomics Consortium, heritability
- MeSH terms
- Adult, C-Reactive Protein, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, International Cooperation, Male, Obesity, Psychiatric Status Rating Scales, Weight Gain, Body Mass Index, Genetic Predisposition to Disease, Diagnostic and Statistical Manual of Mental Disorders, Genome-Wide Association Study, Craving
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review